This company has been acquired
Vapotherm Past Earnings Performance
Past criteria checks 0/6
Vapotherm's earnings have been declining at an average annual rate of -10.3%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been declining at an average rate of 0.4% per year.
Key information
-10.3%
Earnings growth rate
9.4%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | -0.4% |
Return on equity | n/a |
Net Margin | -76.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Vapotherm announces $23M private placement
Feb 08Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M
Nov 02Vapotherm draws downgrade at William Blair after 2Q results
Aug 04Vapotherm: Out Of Air
May 11Is Vapotherm (NYSE:VAPO) Using Too Much Debt?
Jan 24Vapotherm: Hardly Breathing Room
Jul 11Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?
May 10Vapotherm reports Q1 results
May 05The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares
Mar 12Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year
Mar 11Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?
Jan 19Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth
Jan 13Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares
Dec 14Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%
Dec 11Vapotherm shares +9% on higher Q4 guidance
Dec 01Vapotherm: The Game Has Completely Changed
Nov 13Revenue & Expenses Breakdown
How Vapotherm makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 71 | -54 | 45 | 13 |
31 Mar 24 | 70 | -55 | 48 | 14 |
31 Dec 23 | 69 | -58 | 52 | 14 |
30 Sep 23 | 68 | -69 | 58 | 15 |
30 Jun 23 | 66 | -81 | 65 | 17 |
31 Mar 23 | 63 | -108 | 68 | 19 |
31 Dec 22 | 67 | -113 | 75 | 20 |
30 Sep 22 | 70 | -110 | 80 | 21 |
30 Jun 22 | 95 | -98 | 89 | 20 |
31 Mar 22 | 103 | -72 | 94 | 19 |
31 Dec 21 | 113 | -60 | 93 | 18 |
30 Sep 21 | 132 | -58 | 99 | 18 |
30 Jun 21 | 124 | -57 | 92 | 19 |
31 Mar 21 | 139 | -48 | 92 | 19 |
31 Dec 20 | 126 | -52 | 89 | 17 |
30 Sep 20 | 98 | -47 | 76 | 16 |
30 Jun 20 | 78 | -47 | 67 | 14 |
31 Mar 20 | 55 | -52 | 60 | 13 |
31 Dec 19 | 48 | -51 | 56 | 13 |
30 Sep 19 | 47 | -51 | 54 | 12 |
30 Jun 19 | 45 | -48 | 51 | 11 |
31 Mar 19 | 44 | -47 | 49 | 10 |
31 Dec 18 | 42 | -43 | 45 | 9 |
30 Sep 18 | 41 | -39 | 42 | 8 |
30 Jun 18 | 40 | -37 | 39 | 8 |
31 Mar 18 | 38 | -33 | 36 | 8 |
31 Dec 17 | 36 | -31 | 34 | 8 |
31 Dec 16 | 30 | -23 | 26 | 6 |
Quality Earnings: VAPO is currently unprofitable.
Growing Profit Margin: VAPO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VAPO is unprofitable, and losses have increased over the past 5 years at a rate of 10.3% per year.
Accelerating Growth: Unable to compare VAPO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VAPO is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).
Return on Equity
High ROE: VAPO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.